Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study.

M'Kada H, Perazzo H, Munteanu M, Ngo Y, Ramanujam N, Fautrel B, Imbert-Bismut F, Ratziu V, Schuppe-Koistinen I, Leblond V, Delattre JY, Samson Y, Caen OL, Bricaire F, Khayat D, Pierrot-Deseilligny C, Herson S, Amoura Z, Tilleul P, Deckmyn O, Coriat P, Delpech VN, Boulogne P, Bonnefont-Rousselot D, Poynard T; Drug Induced Liver Injury Groupe Hospitalier Pitié-Salpêtrière Group; Safer and Faster Evidence-based Translation Consortium.

PLoS One. 2012;7(8):e42418. Epub 2012 Aug 14.

2.

Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.

Xu HM, Chen Y, Xu J, Zhou Q.

World J Gastroenterol. 2012 Nov 7;18(41):5972-8. doi: 10.3748/wjg.v18.i41.5972.

3.

Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.

Robles-Diaz M, Lucena MI, Kaplowitz N, Stephens C, Medina-Cáliz I, González-Jimenez A, Ulzurrun E, Gonzalez AF, Fernandez MC, Romero-Gómez M, Jimenez-Perez M, Bruguera M, Prieto M, Bessone F, Hernandez N, Arrese M, Andrade RJ; Spanish DILI Registry; SLatinDILI Network; Safer and Faster Evidence-based Translation Consortium.

Gastroenterology. 2014 Jul;147(1):109-118.e5. doi: 10.1053/j.gastro.2014.03.050. Epub 2014 Apr 1.

4.

What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI).

M'Kada H, Munteanu M, Perazzo H, Ngo Y, Ramanujam N, Imbert-Bismut F, Ratziu V, Bonnefont-Rousselot D, Souberbielle B, Schuppe-Koistinen I, Poynard T; DILI group of the SAFE-T consortium.

Regul Toxicol Pharmacol. 2011 Aug;60(3):290-5. doi: 10.1016/j.yrtph.2011.04.002. Epub 2011 Apr 24.

PMID:
21539883
5.

Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.

Fontana RJ, Hayashi PH, Barnhart H, Kleiner DE, Reddy KR, Chalasani N, Lee WM, Stolz A, Phillips T, Serrano J, Watkins PB; DILIN Investigators.

Am J Gastroenterol. 2015 Oct;110(10):1450-9. doi: 10.1038/ajg.2015.283. Epub 2015 Sep 8.

6.

Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.

Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S.

Gastroenterology. 2013 Jun;144(7):1419-25, 1425.e1-3; quiz e19-20. doi: 10.1053/j.gastro.2013.02.006. Epub 2013 Feb 16.

PMID:
23419359
7.

Drug-induced liver injury: a cohort study on patients referred to the Danish transplant center over a five year period.

Baekdal M, Ytting H, Skalshøi Kjær M.

Scand J Gastroenterol. 2017 Apr;52(4):450-454. doi: 10.1080/00365521.2016.1267790. Epub 2016 Dec 15.

PMID:
27973926
8.

Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injury.

Ozer JS, Chetty R, Kenna G, Palandra J, Zhang Y, Lanevschi A, Koppiker N, Souberbielle BE, Ramaiah SK.

Regul Toxicol Pharmacol. 2010 Apr;56(3):237-46. doi: 10.1016/j.yrtph.2009.11.001. Epub 2009 Nov 10.

PMID:
19903504
9.

A prospective study on the causes of notably raised alanine aminotransferase (ALT).

Björnsson HK, Olafsson S, Bergmann OM, Björnsson ES.

Scand J Gastroenterol. 2016;51(5):594-600. doi: 10.3109/00365521.2015.1121516. Epub 2015 Dec 14.

PMID:
26653080
10.

Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury.

Mikus M, Drobin K, Gry M, Bachmann J, Lindberg J, Yimer G, Aklillu E, Makonnen E, Aderaye G, Roach J, Fier I, Kampf C, Göpfert J, Perazzo H, Poynard T, Stephens C, Andrade RJ, Lucena MI, Arber N, Uhlén M, Watkins PB, Schwenk JM, Nilsson P, Schuppe-Koistinen I.

Liver Int. 2017 Jan;37(1):132-140. doi: 10.1111/liv.13174. Epub 2016 Jun 22.

11.

Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts.

Thulin P, Nordahl G, Gry M, Yimer G, Aklillu E, Makonnen E, Aderaye G, Lindquist L, Mattsson CM, Ekblom B, Antoine DJ, Park BK, Linder S, Harrill AH, Watkins PB, Glinghammar B, Schuppe-Koistinen I.

Liver Int. 2014 Mar;34(3):367-78. doi: 10.1111/liv.12322. Epub 2013 Oct 14.

PMID:
24118944
12.

Drug-induced liver injury.

Leise MD, Poterucha JJ, Talwalkar JA.

Mayo Clin Proc. 2014 Jan;89(1):95-106. doi: 10.1016/j.mayocp.2013.09.016. Review.

PMID:
24388027
13.

The Art and Science of Diagnosing and Managing Drug-induced Liver Injury in 2015 and Beyond.

Lewis JH.

Clin Gastroenterol Hepatol. 2015 Nov;13(12):2173-89.e8. doi: 10.1016/j.cgh.2015.06.017. Epub 2015 Jun 23. Review.

PMID:
26116527
14.

Drug-induced liver injury caused by intravenously administered medications: the Drug-induced Liver Injury Network experience.

Ghabril M, Fontana R, Rockey D, Jiezhun G, Chalasani N.

J Clin Gastroenterol. 2013 Jul;47(6):553-8. doi: 10.1097/MCG.0b013e318276bf00.

15.

Predicting and preventing acute drug-induced liver injury: what's new in 2010?

Liss G, Rattan S, Lewis JH.

Expert Opin Drug Metab Toxicol. 2010 Sep;6(9):1047-61. doi: 10.1517/17425255.2010.503706. Review.

PMID:
20615079
16.

Risk factors for liver injury with an elevated serum bilirubin concentration caused by antituberculous drugs.

Kato H, Horita N, Miyazawa N, Yoshiyama T, Ueda A, Ishigatsubo Y.

Intern Med. 2013;52(19):2209-14. Epub 2012 Mar 1.

17.

Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.

Curtis JR, Beukelman T, Onofrei A, Cassell S, Greenberg JD, Kavanaugh A, Reed G, Strand V, Kremer JM.

Ann Rheum Dis. 2010 Jan;69(1):43-7. doi: 10.1136/ard.2008.101378.

18.

Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation.

Sembera S, Lammert C, Talwalkar JA, Sanderson SO, Poterucha JJ, Hay JE, Wiesner RH, Gores GJ, Rosen CB, Heimbach JK, Charlton MR.

Liver Transpl. 2012 Jul;18(7):803-10. doi: 10.1002/lt.23424.

19.
20.

Validation of multivariate outlier detection analyses used to identify potential drug-induced liver injury in clinical trial populations.

Lin X, Parks D, Painter J, Hunt CM, Stirnadel-Farrant HA, Cheng J, Menius A, Lee K.

Drug Saf. 2012 Oct 1;35(10):865-75. doi: 10.2165/11632670-000000000-00000.

PMID:
22928730

Supplemental Content

Support Center